EMV — EMvision Medical Devices Balance Sheet
0.000.00%
- AU$149.66m
- AU$135.96m
- AU$8.85m
Annual balance sheet for EMvision Medical Devices, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6.8 | 9.97 | 18.7 | 10.5 | 17.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.07 | 0 | 2.92 | 3.18 | 4.3 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.07 | 10.2 | 21.9 | 13.9 | 21.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.958 | 0.803 | 0.523 | 1.03 | 0.783 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.51 | 11.5 | 24 | 15.6 | 23 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.854 | 6.04 | 3.41 | 2.84 | 3.92 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.43 | 6.4 | 5.46 | 6.29 | 7.27 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7.08 | 5.12 | 18.5 | 9.28 | 15.8 |
| Total Liabilities & Shareholders' Equity | 8.51 | 11.5 | 24 | 15.6 | 23 |
| Total Common Shares Outstanding |